Literature DB >> 36104721

Correction: Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed.

Khalid B Beshir1, Jonathan B Parr2, Jane Cunningham3, Qin Cheng4,5, Eric Rogier6.   

Abstract

Entities:  

Year:  2022        PMID: 36104721      PMCID: PMC9476575          DOI: 10.1186/s12936-022-04281-9

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   3.469


× No keyword cloud information.

Correction: Malaria Journal (2022) 21:201 10.1186/s12936-022-04226-2

Following publication of the original article [1], the authors requested the following corrections: Page 6 (of the PDF)—This sentence needs revision: “In addition to pfhrp2/3, the three assays published to date target different parasite genes: pfldh [37], pfrnr2e2 [38], and cytb [39]”. In this sentence, change “cytb” to “pfbtub”. Page 6 (of the PDF)—This sentence needs revision: “While pfldh and pfrnr2e2 are single-copy genes, cytb, (like the 18S rRNA gene which has 4–8 copies/genome), is a multicopy gene (30–100 copies per genome) [40] and is expressed in the P. falciparum mitochondria.”. This should be split into two sentences, and should read: “The pfldh, pfrnr2e2, and pfbtub genes are all single-copy which make them the most appropriate as references for reporting pfhrp2/3 genotype. Genes like cytb (similar to the 18S rRNA gene, which has 4–8 copies/genome), is a multicopy gene (30–100 copies per genome) [40] and is expressed in the P. falciparum mitochondria.” Page 6 (of the PDF)—Table 2. Within the table in the second row, the parasite reference gene is listed as ‘pfcytb’ and internal control is ‘Parasite pfbtub’. The reference gene should be listed as ‘Parasite pfbtub’ and internal control as ‘None’.
  1 in total

Review 1.  Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed.

Authors:  Khalid B Beshir; Jonathan B Parr; Jane Cunningham; Qin Cheng; Eric Rogier
Journal:  Malar J       Date:  2022-06-24       Impact factor: 3.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.